IPO paused or DRHP lapsed: what happens, with Indian examples

A draft red herring prospectus (DRHP) is the draft offer document an Indian company files with SEBI before an IPO. SEBI reviews it and sends observations, a letter that lets the company proceed once it fixes the points raised. The observation letter does not stay valid forever. If the company has not opened its issue before the validity ends, the approval lapses.

A lapse is not a ban. It means the company has to go back, update the document and file again, and SEBI looks at the new draft. The earlier work is partly reused, but the time and the legal cost are real.

Under the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, regulation 44 requires a public issue to open within 12 months from the date of SEBI observations, according to law-firm summaries. On the confidential pre-filing route under Chapter IIA, the issue can open within 18 months of the observation letter, but the updated public draft (UDRHP-I) must be filed earlier, within about 16 months, to stay eligible.

Dates are counted from the date of the letter, not from the filing. Companies therefore track the clock closely and often launch near the end of the window.

• Normal route: issue must open within 12 months of observations (regulation 44).
• Pre-filing route: issue within 18 months, with the UDRHP-I filed within about 16 months.
• After a lapse: fresh draft and fresh review.
• One-time relief in 2026: validity extended to 30 September 2026 for letters expiring between 1 April and 30 September 2026.

On 7 April 2026 SEBI issued a one-time circular that extended the validity of observation letters expiring between 1 April and 30 September 2026 until 30 September 2026, according to Business Today and law-firm notes. SEBI cited uncertain markets linked to geopolitical tension and weak investor participation. Companies using the extension had to submit updated offer documents with a compliance confirmation.

A Trilegal note in September 2026 said over thirty issuers faced the 30 September deadline. The full conditions are in the circular itself, which should be read for any specific case. As of November 2026, some of those approvals will have lapsed unless the issues opened.

Common reasons are weak markets, a price that the company or its bankers find too low, a drop in recent listings, a pending change in the numbers, or a need to wait for a longer profit record. Sometimes a company changes the size of the offer or removes a seller before returning.

A delay can also come from SEBI itself, which may ask questions or hold a file. A pause is not a sign of trouble by itself. Reading the reason in the company statement or the news report helps tell weak demand from a normal timing choice.

Pre-IPO investors usually hold shares in a private company, so they cannot sell on an exchange until the company lists. A delay extends their wait. Funds that planned an exit through the IPO may need a secondary sale or a longer holding period.

Employees with stock options face the same wait. For a company that raised a pre-IPO round at a set valuation, a long delay can mean a later listing at a lower price. The guide on unlisted and pre-IPO shares covers the risks of holding in the meantime.

Investors who hold convertible shares face one more detail. Conversion into ordinary shares is usually timed to the IPO, so a long delay can leave preference terms in place for longer than planned. The guide on conversion of preference shares before an IPO covers this.

The company files a fresh DRHP with updated financials and risk disclosures. The document must show the latest audited numbers, so a second filing often looks different from the first. SEBI reviews it again, and the validity clock starts again from the new observation letter.

Where a company used the pre-filing route and missed the UDRHP-I deadline, it also has to restart. Companies sometimes pick the other route on the second try. See the guide on SEBI observations on DRHP.

Yes, and they are easy to find in news from 2025 and 2026. Several startup filings cleared by SEBI waited months before a launch, and some companies said they were watching market conditions. The April 2026 relaxation was itself a response to this pattern, since SEBI noted that issuers were deferring or withdrawing plans.

Any specific name should be checked against the SEBI observation date, the company statement and the exchange record before being called delayed or lapsed. A company that is paused may have been waiting for results, and a company that is silent may be on the confidential route, where information is limited by design. For that reason this guide avoids naming a company without its filing in hand.

StopDown's IPO tracker records filing and listing status for the startups it covers, and the decoded filings in Startup Decoded show what a draft contains. A reader can use both to compare the date of a filing with the date of its observation letter.

When a story says an IPO is delayed or approval has lapsed, three things matter: which date the observation letter carries, which route was used and whether a relaxation applied. Without these, the headline is hard to judge. A story naming a company should be checked against the filing before drawing conclusions.

This guide is general information and not legal or investment advice. Check the SEBI circulars and the company filing for any specific case.